Pfizer, BioNTech Seal Deal to Manufacture COVID-19 Vaccine in South Africa
with agency report Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their COVID-19 vaccine for the African Union. Reuters reported that the firms disclosed this yesterday. The deal is to “fill and finish” the vaccine, the final stages of manufacturing where the product is processed and put into vials. It does not cover the complicated processes of mRNA drug substance production, which Pfizer and BioNTech will do at their own facilities in Europe, the report explained. The agreement comes as Pfizer and BioNT...